All Cases

The petitioner proposes to study how changes in RNA splicing facilitate the growth, spread, and recurrence of glioblastoma brain tumors. He aims to develop small drug-like molecules designed to block these harmful RNA changes to improve treatment efficacy for patients. This work focuses on creating practical therapeutic tools to combat aggressive brain cancers.

The petitioner proposes to discover the underlying mechanisms driving inflammatory processes linked to diseases and aging by analyzing complex immunological multi-omics data. This work focuses on identifying novel therapeutic targets to advance cancer immunotherapy and treatments for neurodegenerative diseases.

The petitioner proposes to safeguard U.S. information systems against current cyberthreats and future quantum-based attacks. His work focuses on post-quantum cryptography, quantum-secure communication, and advanced sensing technologies to develop future-proof security systems.

The petitioner proposes to continue research in biological sciences focusing on the mechanisms of epithelial ion transport regulation. This work explores how these mechanisms are utilized by economically significant animals to understand vectors of infectious diseases, agricultural pests, and species critical for aquaculture. The research aims to improve disease management, agricultural productivity, and biosecurity through cutting-edge biological methodologies.

The petitioner proposes to identify the molecular mechanisms and signaling pathways that modulate cellular metabolism in cancer models. This research focuses on discovering and developing effective therapeutic strategies for metabolic diseases and cancer to reduce the burden on the U.S. healthcare system.

The petitioner proposes to develop a deterministic model using epigenetic signatures to identify individuals at high risk for the onset and relapse of acute myeloid leukemia (AML). This research focuses on advancing precision in early diagnosis through complex molecular profiling to pinpoint early biological markers. The work aims to enable targeted clinical interventions before symptoms escalate, thereby reducing mortality and healthcare disparities associated with aggressive blood cancers.

The petitioner proposes to continue research in biomedical science with a focus on disease modeling, targeted therapy development, and the molecular characterization of rare tumors. The work involves genomic analysis of pediatric and adult tumors to enable personalized treatments and validate the effectiveness of drugs like seribantumab and zenocutuzumab. The intended impact is to address urgent gaps in oncology and overcome drug resistance mechanisms in under-researched cancers.